Lack of association of ace gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients

Genetics and Molecular Research

Volumn 9, Issue 2, 2010, Pages 734-738

  Yakut, T ^a   Karkucak, M ^a   Ursavas, A ^a   Gulten, T ^a   Burgazlioglu, B ^a   Gorukmez, O ^a   Karadag, M ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

ACE gene; Obstructive sleep apnea syndrome; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SLEEP APNEA SYNDROME; TURKEY (REPUBLIC);

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SLEEP APNEA, OBSTRUCTIVE; SYNDROME; TURKEY;

EID: 77954450675     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol9-2gmr755     Document Type: Article

References (20)

1. Agerholm-Larsen B, Nordestgaard BG and Tybjaerg-Hansen A (2000). ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler. Thromb. Vasc. Biol. 20: 484-492.
2. Ahmadi N, Shapiro GK, Chung SA and Shapiro CM (2009). Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography. Sleep Breath. 13: 221-226.
3. Barceló A, Elorza MA, Barbé F, Santos C, et al. (2001). Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur. Respir. J. 17: 728-732.
4. Bengtsson K, Orho-Melander M, Lindblad U, Melander O, et al. (1999). Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. J. Hypertens. 17: 1569-1575.
5. Butler R, Morris AD and Struthers AD (1997). Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin. Sci. 93: 391-400.
6. Candy GP, Skudicky D, Mueller UK, Woodiwiss AJ, et al. (1999). Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 83: 740-744.
7. Lee YJ and Tsai JC (2002). ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25: 1002-1008.
8. Nakai K, Itoh C, Miura Y, Musya T, et al. (1994). Deletion polymorphism of the angiotensin I-converting enzyme gene associates with increased risk for ischemic heart diseases in the Japanese. Rinsho Byori 42: 689-694.
9. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, et al. (1998). Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766-1772.
10. Patel SR, Larkin EK, Mignot E, Lin L, et al. (2007). The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 30: 531-533.
11. Piérola J, Barceló A, de la Peña M, Barbé F, et al. (2007). Beta3-adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur. Respir. J. 30: 743-747.
12. Raynolds MV, Bristow MR, Bush EW, Abraham WT, et al. (1993). Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342: 1073-1075.
13. Rubinsztajn R, Kumor M, Byskiniewicz K and Chazan R (2004). Angiotensin-converting enzyme gene polymorphism in patients with obstructive sleep apnea. Pol. Arch. Med. Wewn. 112: 817-822.
14. Sakai K, Takada T, Nakayama H, Kubota Y, et al. (2005). Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. Intern. Med. 44: 928-933.
15. Schunkert H, Hense HW, Holmer SR, Stender M, et al. (1994). Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330: 1634-1638.
16. Seckin D, Ilhan N, Ilhan N and Ozbay Y (2006). The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin. Biochem. 39: 50-54.
17. Ursavaş A and Ege E (2003). Obstructive sleep apnea and cardiovascular diseases. Anadolu. Kardiyol. Derg. 3: 150-155.
18. Xiao Y, Huang X, Qiu C, Zhu X, et al. (1999). Angiotensin I-converting enzyme gene polymorphism in Chinese patients with obstructive sleep apnea syndrome. Chin. Med. J. 112: 701-704.
19. Yaggi HK, Concato J, Kernan WN, Lichtman JH, et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353: 2034-2041.
20. Yavuz Z, Ursavas A, Ege E, Ozarda IY, et al. (2008). Homocysteine levels in patients with obstructive sleep apnea syndrome. Tuberk. Toraks 56: 37-42.